Clinical evaluation observes botulinum toxin A effectiveness for acute acquired comitant esotropia in young patients, highlighting potential relief after excessive screen use.
To study the effectiveness of botulinum toxin A (BTX-A) in the treatment of patients with acute acquired comitant esotropia (AACE) due to excessive use of mobile and laptops in the COVID era in the pediatric population and adolescents.
No takes yet. Share an insight, caveat, or question.
Pawar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: